Clinical Trial Update: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

View source ↗

Summary

The ISAR-Trial evaluating innovative stratification of arrhythmic risk in female myocardial infarction patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Myocardial Infarction | Status: COMPLETED